Related Experiment Video
Updated: Jan 12, 2026

Preparation, Administration, and Assessment of In Vivo Tissue-Specific Cellular Uptake of Fluorescent Dye-Labeled Liposomes
Published on: July 30, 2020
QbD-guided development of a simvastatin-loaded transethosomal gel for enhanced transdermal delivery: optimization,
Umashri A Kokatanur1, Panchaxari M Dandagi1, Sathgowda Patil2
1Department of Pharmaceutics, KLE College of Pharmacy, Belagavi, KLE Academy of Higher Education and Research (KAHER), Belagavi, India.
Background:
Simvastatin, a lipid-lowering drug, has low oral bioavailability due to poor solubility and extensive first-pass metabolism. Transdermal delivery may overcome these limitations.
Objectives:
The present study aimed to develop, optimize, and evaluate a simvastatin-loaded transethosomal gel for enhanced dermal permeation and improved antihyperlipidemic efficacy.
Methods:
Critical quality attributes, including particle size (PS), entrapment efficiency (%EE), and polydispersity index (PDI), were established through a Quality Target Product Profile. Transethosomes were optimized using a Face-Centered Central Composite Design (FCCCD) by varying Soya phosphatidylcholine and ethanol concentrations. The optimized formulation was characterized using dynamic light scattering, scanning electron microscope, and transmission electron microscope. It was incorporated into a 2% w/v carbopol gel and evaluated for pH, viscosity, and spreadability. In vitro diffusion, ex vivo skin permeation, and skin irritation studies were performed. Antihyperlipidemic efficacy was assessed in high-fat diet-induced hyperlipidemic rats, comparing oral simvastatin (10 mg/kg/day) and transethosomal gel (1 g containing 10 mg simvastatin).
Results:
Optimized vesicles showed nanoscale PS (104.9 ± 0.42 nm), high EE (79.92 ± 0.19%), low PDI (0.113 ± 0.45), and negative zeta potential (-32.1 ± 0.48 mV). Microscopy confirmed spherical morphology. The gel exhibited sustained release, good skin compatibility, and significantly improved lipid profile in high-fat diet-fed rats, reducing total cholesterol (TC), triglycerides (TG), and low-density lipoprotein cholesterol (LDL-C), while elevating high-density lipoprotein cholesterol (HDL-C) compared to oral simvastatin (p < 0.05).
Conclusion:
The simvastatin-loaded transethosomal gel demonstrated superior dermal delivery, efficacy, and safety, supporting its potential as a nanoenabled transdermal alternative for hyperlipidemia management.
Related Concept Videos
Bioavailability Enhancement: Drug Permeability Enhancement
Lipid Absorption
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
Methods for Studying Drug Absorption: In vitro
The diffusion cell method uses a two-compartment cell, including a donor compartment with the drug solution, which simulates the environment where the drug is applied, and a receptor compartment with a buffer solution, which simulates the environment...
Drug Product Performance: In Vitro–In Vivo Correlation

